Schantz P, Moore A, Munoz J, et al. Neurocysticercosis in an Orthodox jewish community in New York City. N Eng J Med 1992; 327: 692-695
Del Brutto, Santibañez R, Noboa C, et al. Epilepsy due to neurocisticercosis; analysis of 203 cases. Neurology 1992, 42: 389-392
Medina MT, et al. Neurocisticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 1990; 150: 323-325
Sotelo J, Del Brutto O, Román G. Cysticercosis. Curr Clin Topics Infect Dis 1996, 16: 240-259
Torres JR. Use of Praziquantel in populations at risk of neurocisticercosis. Rev Inst Med Trop Sao Paulo 1989, 31: 290
Sotelo J, Guerrero V, Rubio F. Neurocisticercosis: a new classification based on active and inactive forms. A study of 753 cases. Arch. Intern. Med. 1985, 145: 442-445
Geme J, Maldonado I, Enzmann D, et al. Consensus: diagnosis and management of neurocisticercosis in children. Ped Infect Dis J 1993, 12: 455-461
Loo L, Braude A. Cerebral cisticercosis in San Diego: a report of 23 cases and a review of the literature. Medicine 1982, 61: 341-359
García E, Ordoñez G, Soltelo G. Antigens from Taenia crassiceps cysticerci used in complement fixation, enzyme-linked immunosorbent assay, and Western blot (immunoblot) for diagnosis of neurocysticercosis. J Clin Microbiol 1996, 33: 3324-3325
Tsang V, Brand J, Boyer A. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cisticercosis (Taenia solium). J Infect Dis 1989, 159: 50-59
Diaz J, Verastegua M, Gilman R, et al. Immunodiagnosis of human cisticercosis (Taenia solium): a field comparisson of an antibody-enzyme-linked immunosorbent assay (ELISA), an antigen-ELISA, and an enzyme-linked immunoelectrotransfer blot (EITB) assay in Peru. Am J Trop Med Hyg 1992, 46: 610-615
Del Brutto O, Sotelo J, Roman G. Therapy of neurocisticercosis: a reappraisal. Clin Infect Dis 1993, 17: 730-55. Torres JR, Noya O, Noya BA, Mondolfi A. Seizures and Praziquantel. A case report. Rev. Inst. Med Trop Sao Paulo 1988, 30: 433-436
Carpio A, Santillan F, León P, et al. Is the course of neurocysticercosis modified by treatment with antihelminthic agents?. Arch Intern Med 1995, 155: 1982-1986.
Del Brutto O. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? (Letter). Arch Intern Med 1997, 157: 128-129
Vazquez V, Sotelo J. The course of seizures after treatment for cerebral cisticercosis. N Eng J Med 1992, 327: 69616.
Takayanugui O, Jardin E. Therapy for neurocisticercosis: comparison between albendazole and praziquantel. Arch Neurol 1992, 45: 532-534
Mitchell WG, Crawford TO. Intraparenchymal cerebral cisticercosis in children: diagnosis and treatment. Pediatrics 1988; 82: 76-82
Takayanagui O and Jardim E. Therapy for neurocisticercosis. Comparison between albendazole and praziquantel. Arch Neurol 1992, 49: 290-294
Jung H, Hurtado M, Medina T, et al. Dexamethasone increases plasma levels of albendazole. J Neurol 1990, 237: 69-72
Bonametti A, Baldy J, Bortoliero A, et al. Neurocisticercose com quadro clinico inicial de meningite aguda. Rev Inst Med Trop Sao Paulo 1994, 1: 27-32
Gonzales A, García H, Gilman R, et al. Effective single-dose treatment of porcine cysticercosis with oxfendazole. Am J Trop Med Hyg 1996, 54: 381-384
NOTA:Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.
Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO, caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit
